To read more on this topic click here.
Scottish university reveals multimillion-pound Parkinson’s research partnership
Author: Roisin McCormackPublished: 10 July 2019
Prep: Cook: Serves:
The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s.
Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition.
The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development.
Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together.
“This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”
Share this story
Parkinson’s podcast: DBS – a report from the front lines
Get the low-down on new surgical and non-surgical interventionsREAD MORE
Meet Julie Dodd, director of digital transformation at Parkinson’s UK
“I know many fantastic female leaders in the charity sector”READ MORE
Dopamine agonists for Parkinson’s: a simple introduction
Find out more about the Parkinson’s medicationREAD MORE